149 related articles for article (PubMed ID: 8009188)
1. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation.
Saha HH; Salmela KT; Ahonen PJ; Pietilä KO; Mörsky PJ; Mustonen JT; Lalla ML; Pasternack AI
Scand J Urol Nephrol; 1994 Mar; 28(1):21-7. PubMed ID: 8009188
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of renal transplantation on the metabolism of vitamin D3.
Saha H; Salmela K; Ahonen J; Pietilä K; Mörsky P; Pasternack A
Transplant Proc; 1992 Feb; 24(1):367-8. PubMed ID: 1539320
[No Abstract] [Full Text] [Related]
3. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
Saha H
Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
[TBL] [Abstract][Full Text] [Related]
7. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients.
Steiner RW; Ziegler M; Halasz NA; Catherwood BD; Manolagas S; Deftos LJ
Transplantation; 1993 Oct; 56(4):843-6. PubMed ID: 8212205
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
9. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
Rudnicki M; McNair P; Transbøl I; Nielsen B
Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
[TBL] [Abstract][Full Text] [Related]
10. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
12. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
Lobo PI; Cortez MS; Stevenson W; Pruett TL
Clin Transplant; 1995 Aug; 9(4):277-81. PubMed ID: 7579733
[TBL] [Abstract][Full Text] [Related]
13. Serum calcitriol concentrations in the early follow-up after renal transplantation.
Bonnin MR; González MT; Díez O; Blanco A; Bover J; Griñó JM; Navarro MA
Transplant Proc; 1992 Feb; 24(1):103-4. PubMed ID: 1539194
[No Abstract] [Full Text] [Related]
14. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
[TBL] [Abstract][Full Text] [Related]
15. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly.
Souberbielle JC; Cormier C; Kindermans C; Gao P; Cantor T; Forette F; Baulieu EE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3086-90. PubMed ID: 11443171
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure.
Yumita S; Suzuki M; Akiba T; Akizawa T; Seino Y; Kurokawa K
Tohoku J Exp Med; 1996 Sep; 180(1):45-56. PubMed ID: 8933671
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
Wolf M; Weir MR; Kopyt N; Mannon RB; Von Visger J; Deng H; Yue S; Vincenti F
Transplantation; 2016 Jan; 100(1):184-93. PubMed ID: 26177089
[TBL] [Abstract][Full Text] [Related]
20. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
